Medtronic (MDT): EVP & Pres Neuroscience sold ~$551K

~$551K

Approx. value · 6,850 sh @ $80.41

44K

Holds after · shares reported

Traded

Jan 8, 2025

Filed

Jan 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 6, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
2. Jan 8, 2025 · this disclosureInsiderOfficer sold ~$551K of MDT shares in the open market

What came next

1. Jan 8, 2025InsiderOfficer sold ~$241K of MDT shares in the open market
2. Jan 24, 2025InsiderOfficer sold ~$1.12M of MDT shares in the open market
3. Jan 31, 2025FDARecall: MiniMed insulin pump, REF: 770G (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)
4. Jan 31, 2025FDARecall: MiniMed insulin pump, REF: 630G (MMT-1714, MMT-1715, MMT-1754, MMT-1755)
5. Jan 31, 2025FDARecall: MiniMed insulin pump, REF: 720G (MMT-1809, MMT-1810, MMT-1859, MMT-1860, MMT-1867)
6. Feb 5, 2025FDARecall: Aortic Root Cannula: 1. DLP Aortic Root Cannula A. CANNULA 11012 AR FLOWGUARD 12GA, model no 11012 B. CANNULA 11014 AR FLOWGUARD 14GA, model no. 11014 2. MiAR…
7. Feb 25, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
8. Feb 26, 2025FDARecall: Shiley Adult Flexible Tracheostomy Tube with TaperGuard Cuff Reusable Inner Cannula, REF: 7CN80R
9. Mar 4, 2025FDARecall: InPen smart insulin pen, REF: MMT-105NNBLNA, MMT-105NNGYNA, MMT-105NNPKNA, MMT-105ELBLNA, MMT-105ELGYNA, MMT105ELPKNA
10. Mar 4, 2025FDARecall: Stimulation RC Clinician Programmer Application, Model A71400, when used with the Inceptiv (Model 977119) and Intellis Pro (Model 977118) neurostimulators
11. Mar 4, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
12. Mar 10, 2025FDAFDA device clearance: Duet External Drainage and Monitoring System (EDMS)
13. Mar 10, 2025FDARecall: NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM 4.0, REF: NIM4CM01; CONSOLE NIM4CM01RF NIM 4.0 REFURBISHED, REF: NIM4CM01RF; PATIENT INTERFACE NIM4CPB1…
14. Mar 20, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
15. Mar 24, 2025CongressDisclosed sale of MDT — reported range $50,001 - $100,000
16. Mar 27, 2025FDAFDA device clearance: SelectSite C304 Deflectable Catheter System (C304); C315 Delivery System (C315)
17. Apr 3, 2025FDARecall: Enhanced Verify Evaluation Handset (CFN HH90130FA)
18. Apr 8, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
19. Apr 22, 2025FDAFDA device clearance: Adaptix™ Interbody System with Titan nanoLOCK™ Surface Technology
20. Apr 22, 2025FDAFDA device approval: OmniaSecure™ MRI SureScan™ Lead Model 3930M

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 40 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by Brett A. Wall, EVP & Pres Neuroscience

• SEC Form 4 at Medtronic (MDT)Jan 27, 2025
• SEC Form 4 at Medtronic (MDT)Jan 10, 2025

The full history of Brett A. Wall, EVP & Pres Neuroscience is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Medtronic

• SEC Form 4Oct 16, 2026
• SEC Form 4Oct 16, 2026
• SEC Form 144Oct 15, 2026
• SEC Form 144Oct 15, 2026
• SEC Form 4Sep 18, 2026
• SEC Form 144Sep 16, 2026

Everything OQRO holds on this company is on its MDT page.